Steroid protection in aging and age-associated diseases

Neuroactive steroids are secretory products of peripheral endocrine glands that modulate a variety of brain functions. A close relationship between neuroactive steroid structure and function becomes most evident under pathological circumstances. On one side, overproduction of glucocorticoid and mine...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: De Nicola, A.F
Otros Autores: Pietranera, L., Beauquis, J., Ferrini, M.G, Saravia, F.E
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2009
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 13472caa a22014057a 4500
001 PAPER-23277
003 AR-BaUEN
005 20230518205456.0
008 190411s2009 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-57349192117 
024 7 |2 cas  |a argipressin, 113-79-1; corticosterone, 50-22-6; dexamethasone, 50-02-2; hydrocortisone, 50-23-7; Estradiol, 50-28-2; Glucocorticoids; Mineralocorticoids; Neuroprotective Agents 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a EXGEA 
100 1 |a De Nicola, A.F. 
245 1 0 |a Steroid protection in aging and age-associated diseases 
260 |c 2009 
270 1 0 |m De Nicola, A.F.; Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental, Obligado 2490, 1428 Buenos Aires, Argentina; email: denicola@dna.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Baulieu, E.E., Robel, P., Schumacher, M., Neurosteroids: beginning of the story (2001) Int. Rev. Neurobiol., 46, pp. 1-32 
504 |a Behl, C., Estrogen as a neuroprotective hormone (2002) Nat. Rev. Neurosci., 3, pp. 433-442 
504 |a Brismar, T., Maurex, L., Cooray, G., Juntti-Berggren, L., Lindström, P., Ekberg, K., Adner, N., Andersson, S., Predictors of cognitive impairment in type 1 diabetes (2007) Psychoneuroendocrinology, 32, pp. 1041-1051 
504 |a Cameron, H.A., McKay, R.D., Restoring production of hippocampal neurons in old age (1999) Nat. Neurosci., 2, pp. 894-897 
504 |a Darnaudery, M., Perez-Martin, M., Belizaire, G., Maccari, S., Garcia-Segura, L.M., Insulin-like growth factor 1 reduces age-related disorders induced by prenatal stress in female rats (2006) Neurobiol. Aging, 27, pp. 119-127 
504 |a De Kloet, E.R., Derijk, R.H., Meijer, O.C., Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? (2007) Nat. Clin. Pract. Endocrinol. Metab., 3, pp. 168-179 
504 |a De Nicola, A.F., Magariños, A.M., Foglia, V.G., Neuroendocrine regulation in experimental diabetes (Houssay Lecture) (1991) Diabetes, pp. 3-8. , Rifkin H., Colwell J.A., and Taylor S.I. (Eds), Elsevier Science Publishers 
504 |a De Nicola, A.F., Saravia, F.E., Beauquis, J., Pietranera, L., Ferrini, M.G., Estrogens and neuroendocrine hypothalamic-pituitary-adrenal axis function (2006) Front. Horm. Res., 35, pp. 157-168 
504 |a Ferrini, M., Piroli, G., Frontera, M., Falbo, A., Lima, A., De Nicola, A.F., Estrogens normalize the hypothalamic-pituitary-adrenal axis response to stress and increase glucocorticoid receptor immuno-reactivity in hippocampus of aging male rats (1999) Neuroendocrinology, 69, pp. 129-137 
504 |a Funder, J.W., Aldosterone, mineralocorticoid receptors and vascular inflammation (2004) Mol. Cell. Endocrinol., 217, pp. 263-269 
504 |a Garcia-Segura, L.M., Sanz, A., Mendez, P., Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection (2006) Neuroendocrinology, 84, pp. 275-279 
504 |a Goodman, Y., Bruce, A.J., Cheng, B., Mattson, M.P., Estrogens attenuate and CORT exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons (1996) J. Neurochem., 66, pp. 1836-1844 
504 |a Isgor, C., Watson, S.J., Estrogen receptor alpha and beta mRNA expressions by proliferating and differentiating cells in the adult rat dentate gyrus and subventricular zone (2005) Neuroscience, 134, pp. 847-856 
504 |a Kempermann, G., Gast, D., Gage, F.H., Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment (2000) Ann. Neurol., 52, pp. 135-143 
504 |a Lacreuse, A., Effects of ovarian hormones on cognitive function in nonhuman primates (2006) Neuroscience, 138, pp. 859-867 
504 |a Lephart, E.D., Galindo, E., Bu, L.H., Stress (hypothalamic-pituitary-adrenal axis) and pain response in male rats exposed lifelong to high vs. low phytoestrogen diets (2003) Neurosci. Lett., 342, pp. 65-68 
504 |a Liu, F., Day, M., Muñiz, L.C., Bitran, D., Arias, R., Revilla-Sanchez, R., Grauer, S., Brandon, N.J., Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory (2008) Nat. Neurosci., 11, pp. 334-343 
504 |a McEwen, B.S., Estrogen actions throughout the brain (2002) Rec. Progr. Horm. Res., 57, pp. 357-370 
504 |a Miller, D.B., O'Callaghan, J.P., Aging, stress and the hippocampus (2005) Ageing Res. Rev., 4, pp. 123-140 
504 |a Oomen, C.A., Mayer, J.L., de Kloet, E.R., Joëls, M., Lucassen, P.J., Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress (2007) Eur. J. Neurosci., 26, pp. 3395-3401 
504 |a Perez-Martin, M., Salazar, V., Castillo, C., Ariznavarreta, C., Azcoitia, I., Garcia-Segura, L.M., Tresguerres, J.A., Estradiol and soy extract increase the production of new cells in the dentate gyrus of old rats (2005) Exp. Gerontol., 40, pp. 450-453 
504 |a Petersen, R.C., Jack Jr., C.R., Xu, Y.C., Waring, S.C., O'Brien, P.C., Smith, G.E., Ivnik, R.J., Kokmen, E., Memory and MRI-based hippocampal volumes in aging and AD (2000) Neurology, 54, pp. 581-587 
504 |a Pietranera, L., Saravia, F., Gonzalez Deniselle, M.C., Roig, P., Lima, A., De Nicola, A.F., Abnormalities of the hippocampus are similar in deoxycorticosterone acetate-salt hypertensive rats and spontaneously hypertensive rats (2006) J. Neuroendocrinol., 18, pp. 466-474 
504 |a Pietranera, L., Saravia, F.E., Roig, P., Lima, A., De Nicola, A.F., Protective effects of estradiol in the brain of rats with genetic or mineralocorticoid-induced hypertension (2008) Psychoneuroendocrinology, 33, pp. 270-281 
504 |a Rahmouni, K., Barthelmebs, M., Grima, M., Imbs, J.L., De Jong, W., Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats (2001) Hypertension, 38, pp. 902-906 
504 |a Resnick, S.M., Maki, P.M., Rapp, S.R., Espeland, M.A., Brunner, R., Coker, L.H., Granek, I.A., Shumaker, S.A., Women's health initiative study of cognitive aging investigators. effects of combination estrogen plus progestin hormone treatment on cognition and affect (2006) J. Clin. Endocrinol. Metab., 91, pp. 1802-1810 
504 |a Sapolsky, R., Krey, L.C., McEwen, B.S., The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis (1986) Endocr. Rev., 7, pp. 284-304 
504 |a Saravia, F.E., Beauquis, J., Pietranera, L., De Nicola, A.F., Neuroprotective effects of estradiol in the hippocampus of middle age mice: involvement of neurons and glial cells (2007) Psychoneuroendocrinology, 32, pp. 480-492 
504 |a Saravia, F., Revsin, Y., Lux-Lantos, V., Beauquis, J., Homo-Delarche, F., De Nicola, A.F., Oestradiol restores cell proliferation in dentate gryus and subventricular zone of streptozotocin-diabetic mice (2004) J. Neuroendocrinol., 16, pp. 704-710 
504 |a Scharfman, H.E., Maclusky, N.J., Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? (2005) Trends Neurosci., 28, pp. 79-85 
504 |a Sherwin, B.B., Henry, J.F., Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review (2008) Front. Neuroendocrinol., 29, pp. 88-113 
504 |a Shughrue, P.J., Lane, M.V., Merchentaler, I., Comparative distribution of estrogen receptor α and β mRNA in the rat central nervous system (1997) J. Comp. Neurol., 388, pp. 507-525 
504 |a Smith, R.G., Betancourt, L., Sun, Y., Molecular endocrinology and physiology of the aging central nervous system (2005) Endocr. Rev., 26, pp. 203-250 
504 |a Tanapat, P., Hastings, N.B., Gould, E., Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner (2005) J. Comp. Neurol., 481, pp. 252-265 
504 |a Verret, L., Trouche, S., Zerwas, M., Rampon, C., Hippocampal neurogenesis during normal and pathological aging (2007) Psychoneuroendocrinology, 32 (SUPPL. 1), pp. S26-S30 
504 |a Wong, E.Y.H., Herbert, J., Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus (2005) Eur. J. Neurosci., 22, pp. 785-792 
520 3 |a Neuroactive steroids are secretory products of peripheral endocrine glands that modulate a variety of brain functions. A close relationship between neuroactive steroid structure and function becomes most evident under pathological circumstances. On one side, overproduction of glucocorticoid and mineralocorticoid neuroactive steroids may be detrimental to the hippocampus, which is enriched in glucocorticoid receptors (GR) and mineralocorticoid receptors (MR). Thus, a dysfunction of the adrenocortical system in aging and age-associated diseases (diabetes, hypertension) is able to cause hippocampal damage. Whereas aging and uncontrolled diabetes show a predominant GR overdrive, a MR overdrive characterizes hypertensive animals. Some abnormalities commonly found in the hippocampus of aging, diabetic and hypertensive animals include decreased neurogenesis, astrogliosis and neuronal loss in the hilus of the dentate gyrus (DG). On the other side, and in contrast to adrenal gland-derived steroids, estrogens qualify as hippocampal neuroprotectants. Given to middle-age mice, estrogens stimulated proliferation and differentiation of newborn cells in the DG, decreased astrogliosis and increased hilar neuronal number. Similar estrogen effects were obtained in mice with streptozotocin-induced diabetes and in spontaneously hypertensive rats (SHR). The results suggest that in aging and age-associated diseases, adrenocortical steroid overdrive sensitizes the hippocampus to the pathological milieu imposed by a pre-existing degeneration or illness. In this setting, estradiol neuroprotection rescues hippocampal parameters previously altered by the pathological environment. © 2008 Elsevier Inc. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Universidad de Buenos Aires, M022 
536 |a Detalles de la financiación: National Council for Scientific Research 
536 |a Detalles de la financiación: Fondo para la Investigación Científica y Tecnológica, BID 1728 OC AR PICT 2004 25610 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas, PIP 5542 
536 |a Detalles de la financiación: We thank the following institutions for financial support: FONCYT (BID 1728 OC AR PICT 2004 25610), the National Research Council of Argentina (CONICET, PIP 5542) and the University of Buenos Aires (M022). 
593 |a Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental, Obligado 2490, 1428 Buenos Aires, Argentina 
593 |a Department of Human Biochemistry, Faculty of Medicine, University of Buenos Aires, Argentina 
593 |a Division of Urology, Harbor-UCLA Medical Center, Torrance, CA 90502, United States 
690 1 0 |a AGING 
690 1 0 |a ARGININE VASOPRESSIN 
690 1 0 |a ASTROGLIOSIS 
690 1 0 |a DIABETES MELLITUS 
690 1 0 |a ESTRADIOL 
690 1 0 |a HYPERTENSION 
690 1 0 |a NEUROGENESIS 
690 1 0 |a NEUROPROTECTION 
690 1 0 |a ARGIPRESSIN 
690 1 0 |a CORTICOSTERONE 
690 1 0 |a DEXAMETHASONE 
690 1 0 |a HYDROCORTISONE 
690 1 0 |a MINERALOCORTICOID RECEPTOR 
690 1 0 |a AGING 
690 1 0 |a ALZHEIMER DISEASE 
690 1 0 |a ASTROCYTOSIS 
690 1 0 |a DENTATE GYRUS 
690 1 0 |a HIPPOCAMPUS 
690 1 0 |a HUMAN 
690 1 0 |a HYPERTENSION 
690 1 0 |a NERVOUS SYSTEM DEVELOPMENT 
690 1 0 |a NEUROPROTECTION 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a SHORT SURVEY 
690 1 0 |a STEROID METABOLISM 
690 1 0 |a STREPTOZOCIN DIABETES 
690 1 0 |a ADRENAL CORTEX 
690 1 0 |a AGED 
690 1 0 |a AGING 
690 1 0 |a ANIMALS 
690 1 0 |a DIABETES MELLITUS 
690 1 0 |a ESTRADIOL 
690 1 0 |a GLUCOCORTICOIDS 
690 1 0 |a HIPPOCAMPUS 
690 1 0 |a HUMANS 
690 1 0 |a HYPERTENSION 
690 1 0 |a MIDDLE AGED 
690 1 0 |a MINERALOCORTICOIDS 
690 1 0 |a NEUROPROTECTIVE AGENTS 
690 1 0 |a RATS 
690 1 0 |a RATS, INBRED STRAINS 
690 1 0 |a ANIMALIA 
690 1 0 |a MUS 
690 1 0 |a RATTUS 
700 1 |a Pietranera, L. 
700 1 |a Beauquis, J. 
700 1 |a Ferrini, M.G. 
700 1 |a Saravia, F.E. 
773 0 |d 2009  |g v. 44  |h pp. 34-40  |k n. 1-2  |p Exp. Gerontol.  |x 05315565  |t Experimental Gerontology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-57349192117&doi=10.1016%2fj.exger.2008.03.005&partnerID=40&md5=da3b401599d6e2d41a75efe310c5db0c  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.exger.2008.03.005  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_05315565_v44_n1-2_p34_DeNicola  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_05315565_v44_n1-2_p34_DeNicola  |y Registro en la Biblioteca Digital 
961 |a paper_05315565_v44_n1-2_p34_DeNicola  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 84230